The Director General of the National Agency for Pharmaceutical Products, Kamal Mansouri, announced, today, Tuesday, Feb 02nd, 2021, that the production process of the Russian “Sputnik v” vaccine will begin in the coming weeks.
As such, the same official said that the talks with the Russian side are “very advanced” to start the production process of “Sputnik V” within the next few weeks.
The spokesman added, in a statement to public television, that “the time has come to transform Algeria from an importer of vaccines to an exporter.”
The Director-General said that Algeria will work, in the first stage, to cover the national demand for the vaccine, and as a second stage to export it abroad, especially to neighboring countries.
The operation will be carried out – according to Mansouri – in partnership between the public “Saidal” and private Algerian companies that have the necessary expertise in producing medicines.
Earlier, Algeria and Russia agreed, in an audience granted, Sunday, by Prime Minister Abdelaziz Djerad to Russia’s ambassador to Algiers Igor Beliaev, to initiate contacts to establish a bilateral cooperation in the manufacturing of the Russian Covid-19 vaccine “Sputnik V” in Algeria, the Prime Minister’s Office said in a statement.
“The two parties agreed to initiate contacts between the competent services of the two countries with the aim of establishing a bilateral cooperation…,” it said in a statement.
Algeria started its vaccination campaign on Saturday, a day after receiving 50,000 doses of Sputnik V. A shipment of the AstraZeneca vaccine arrived, also, on Monday.
The vaccination campaign, to last throughout 2021 was symbolically kicked off Blida (50km west of Algiers), the first national cluster of the pandemic, which appeared over a year ago.
The operation will concern, in a first step, people prone to infections and transmissions, notably staff of the medical sector, the elderly and people with chronic disease. It will, also, be extended, as from Sunday, to cover other sectors, namely; Police services and Civil Protection, education and also Imams, political officials and the media body.
According to TASS, on August 11, Russia became the first country in the world to register a coronavirus vaccine named Sputnik V, which was developed by the Gamaleya Research Institute of Epidemiology and Microbiology of the Russian Health Ministry. The jab passed clinical trials in June-July. The post-registration trials of Sputnik V began in Moscow on September 7, volunteers received the first vaccine already on September 9.